Jump to content

Sotio

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by ArtZ72 (talk | contribs) at 08:58, 7 March 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Sotio a.s. [1] is a biotechnology company belonging to the PPF Group owned by Petr Kellner. Since March 2014, the head of the company is Ladislav Bartoníček,[2] the former head of Česká pojišťovna (Czech Insurance Company). The company focuses on research and development of medicines for cancer and autoimmune diseases.[3] Besides European countries, it also operate in the USA, Russia and China.[1] In 2014, the Sotio company opened a laboratory complex in China where it produce drugs for people suffering from oncological diseases.[4] Similar laboratories opened in Prague in 2011 already.

The company became well known for developing drugs for prostate cancer, ovarian cancer [5] and lung cancer.[3][6]

References

  1. ^ a b "The company - About us - Sotio a.s." sotio.com.
  2. ^ "Kellnerovo biotechnologické Sotio povede exšéf České pojišťovny Bartoníček". Hospodářské noviny.
  3. ^ a b "Kellnerova firma Sotio zahájila testy léku na rakovinu plic". E15.cz.
  4. ^ "Firma Sotio otevřela v Číně laboratoř, má pomoci proti rakovině". mednes.cz.
  5. ^ "Kellnerova firma začala test léku na rakovinu vaječníků". Aktuálně.cz - Víte co se právě děje.
  6. ^ Zuzana Kubátová (6 January 2015). "Kellnerova firma začíná testovat už třetí lék, tentokrát na nádory plic". iDNES.cz.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Sotio&oldid=708738739"